Estimates for cervical abnormalities in Vanuatu

Australian and New Zealand Journal of Public Health

Volumn 31, Issue 6, 2007, Pages 571-575

  Fotinatos, Nina ^a,b   Warmington, Adrian ^b   Walker, Todd ^a   Pilbeam, Mark ^b  

^a CHARLES STURT UNIVERSITY   (Australia)

^b St John of God Pathology ^*  (Australia)

Author keywords

Developing countries; Papanicolaou smear; Uterine cervical neoplasm; Vanuatu

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER GRADING; CANCER PREVENTION; CANCER SCREENING; DEVELOPING COUNTRY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRECANCER; PREVALENCE; URBAN RURAL DIFFERENCE; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX EPITHELIUM; VANUATU; WOMEN'S HEALTH;

ADOLESCENT; ADULT; AGED; CERVIX UTERI; DEVELOPING COUNTRIES; EPIDEMIOLOGIC STUDIES; EPITHELIUM; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; NEW SOUTH WALES; PREVALENCE; UTERINE CERVICAL DISEASES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; VANUATU; VICTORIA;

EID: 38349011047     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-6405.2007.00146.x     Document Type: Article

References (36)

1. Population Reference Bureau [homepage on the Internet]. Washington (DC): PRB; 2004 [cited 2005 May 15]. Preventing Cervical Cancer Worldwide. Available from: http://www.prb.org/pdf05/ PrevenCerCancer_Eng.pdf
2. Sherris J, Herdman C, Elias C. Beyond our borders: Cervical cancer in the developing world. West J Med. 2001;175(4):231-35.
3. Hoffman M, Cooper D, Carrara H, Rosenberg L, et al. Limited pap screening associated with reduced risk of Cervical Cancer in South Africa. Int J Epidemiol. 2003;32:573-7.
4. Schiffman M, Castle PE. The Promise of Global Cervical-Cancer Prevention. N Engl J Med. 2005;353(20):2101-4.
5. Yabroff KR, Lawrence WF, Mangan P, Washington KS, et al. Geographical disparities in Cervical Cancer mortality: what are the roles of risk factors prevalence, screening, and the use of recommended treatment? (Abstract). J Rural Health. 2005;21(2):149-57.
6. Bayo S, Boasch FX, de Sanjose S, Munoz N, et al. Risk factors of invasive Cervical Cancer. Int J Epidemiol. 2002;31:202-9.
7. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, et al. Cost-effectiveness of cervical cancer screening in five developing countries. N Engl J Med. 2005;353:2158-68.
8. Howe SL, Vargas DE, Granada D, Smith JK. Cervical cancer prevention in remote rural Nicaragua: A program evaluation. Gynecol Oncol. 2005;99 Suppl 3:232-5.
9. Chen CA, Heish CY. Recent advances and problems in primary therapy for cervical cancer in Taiwan. J Formos Med Assoc. 2004;103(7): 511-8.
10. Katz IT, Wright AA. Preventing cervical cancer in the developing world. N Engl J Med. 2006;354(11): 1110.
11. Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ. 2001;79(10):954-63.
12. Mandelblatt JS, Lawrence WF, Gaffikin L, Limpahayom KK. Costs and benefits to different strategies to screen for Cervical Cancer in less-developed countries J Natl Cancer Inst. 2002;94(1): 1469-85.
13. Suba EJ. Crossing the quality chasm: a requirement for successful cervical cancer prevention in developing countries. Clin Lab Med. 2004;24:945-63.
14. Wasti S, Ahmed W, Jafri A, Khan B, et al. Analysis of cervical smears in a Muslim population. Ann Saudi Med. 2004;24(3): 189-92.
15. Denny L. The prevention of cervical cancer in developing countries. BJOG: an international journal of obstetrics and gynaecology. 2005; 112:1204-12.
16. New Zealand International Aid & Development Agency [homepage on the Internet]. Wellington (NZ): NZAID; 2005 [cited 2006 May 1]. Vanuatu Overview. Available from: http://www.nzaid.govt.nz/programmes/ c-vanuatu.html
17. Australian Business Volunteers [homepage on the Internet]. Canberra(AUST): ABV; 2004 [cited 2006 May 1]. Republic of Vanuatu and Business Volunteers: A Country Strategy for the Period 2005-2010. Available from: http://www.abv.org.au/media/7869/ abv%20country%20strategy%20-%20vanuatu.pdf
18. Vanuatu Statistics Office [homepage on the Internet]. Port Vila (VUT): The Office; 2003 [cited on 2006 Oct 17]. Facts on Population of Vanuatu. Available from: http://www.vanuatustatistics.gov.vu/ About%20VNSO/Data/Social/Population.htm
19. Country Health Information Profile 2006. Western Pacific Region Health Databank, 2006 Revision [cited on 2006 Nov 161. Available from: http://www.wpro.who.int/NR/rdonlyres/ 88C2AF48-6F66-4FBB-BDA6-85ABE8FTFEA4/0/van_hdb06.pdf
20. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000. Cancer Incidence, Mortality and Prevalence Worldwide. Version 1.0. Lyon (FRA): IARC Press; 2001 [cited 2006 May 1]. IARC Cancer Base No. 5. Available from: http://wwwdep.iarc.fr/globocan/globocan.html
21. Stewart JM. Cervical cytology study in Port Vila, Vanuatu. Venereology. 1996;9(4):249-53.
22. Huff BC. Abnormal cervical cytology in pregnancy: a laboratory and clinical. dermatological perspective. J Perinat Neonatal Nurs. 2000; 14(1):52-62.
23. Watkins RS, Moran WP. Competency-based learning: The impact of targeted resident education and feedback on Pap smear rates. J Gen Intern Med. 2004;19(5):545-8.
24. Naud P, Matos J, Hammes L, Prolla J, et al. Cervical cancer screening in Porto Alegro, Brazil: Alternative methods for detecting cancer precursors in a developing country. J Low Genit Tract Dis. 2001;5(1):24-8.
25. Victorian Cervical Cytology Registry. Statistical Report 2005. VCCR, Carlton South, Victoria. Available from: http://vccr.or/downloads/ stats%20report%202005.pdf [cited 2006 13 July].
26. Castellsague X, Munoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis - role of parity, oral contraceptive, and tobacco smoking. J Natl Cancer Inst Monogr. 2003;31:20-8.
27. Chan PKS, Chang AR, Tam W, Cheung JLK, et al. Prevalence and genotype distribution of cervical human papillomavirus infection: comparison between pregnant women and non-pregnant controls. J Med Virol. 2002;167:583-8.
28. Kahn JA. Vaccination as a prevention strategy for human papillomavirus-related disease. J Adolesc Health. 2005;37 Suppl 6:10-6.
29. Franceschi S, Rajkumar T, Vaccarella S, Gajalakshmi V et al. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study (Abstract). Int J Cancer. 2003;107(1):127-33.
30. Zhao F, Forman MR, Belinson J. Risk factors for HPV infection and Cervical Cancer among unscreened women in a high-risk rural area of China. Int J Cancer. 2006; 118(2):442-8.
31. Mauad EC, Gomes UA, Nogueira JL, Melani AGF, et al. Prevention of cervical cancer in a poor population in Brazil. Fam Pract. 2002;19:189-92.
32. Wiwanitkit V. Screening for cervical cancer, results from Thailand. Asian Pac J Cancer Prev. 2006;7(2):329-30.
33. Hamad HMA. Cancer initiatives in Sudan. Ann Oncol. 2006;Suppl 8:32-6.
34. Basile S, Angioli R, Manci N, Palaia I, et al. Gynaecological cancers in developing countries: the challenges of chemotherapy in low-resource settings. Int J Gynecol Cancer. 2006; 16(4): 1491-7.
35. Zeferino LC, Derchain SF. Cervical cancer in the developing world. Best Pract Res Clin Obstet Gynaecol. 2006;20(3):339-54.
36. Denny L, Quinn M, Sankaranarayanan R. Screening for cervical cancer in developing countries. Vaccine. 2006;24 Suppl 3:71-7.